NorthRock Partners LLC Raises Position in Intuitive Surgical, Inc. $ISRG

NorthRock Partners LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% in the second quarter, HoldingsChannel.com reports. The fund owned 4,711 shares of the medical equipment provider’s stock after acquiring an additional 25 shares during the period. NorthRock Partners LLC’s holdings in Intuitive Surgical were worth $2,560,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Chilton Capital Management LLC increased its position in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. TD Capital Management LLC increased its position in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 335 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director owned 739 shares in the company, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $429.59 on Monday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business has a fifty day moving average price of $458.68 and a 200-day moving average price of $497.84. The firm has a market capitalization of $154.00 billion, a P/E ratio of 59.91, a PEG ratio of 4.51 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the business posted $1.78 earnings per share. The firm’s revenue was up 21.4% compared to the same quarter last year. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. UBS Group increased their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research report on Wednesday, July 23rd. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 4th. The Goldman Sachs Group reduced their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday, October 1st. Finally, Piper Sandler reissued an “overweight” rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $589.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.